Glycemic variability remains a concern even in T2D patients with well-controlled glucose status June 22, 2022Diabetes
Glycemic variability remains a concern even in T2D patients with well-controlled glucose status June 22, 2022Diabetes
T2D: Noninferior efficacy with adding low-dose vs. standard-dose lobeglitazone to metformin and DPP4iJune 22, 2022Diabetes
T2D: Meta-analysis suggests superiority of tirzepatide over other glucose lowering therapiesJune 22, 2022Diabetes
OGTT prognostic for T2D risk in nulliparous pregnant women testing negative for GDJune 22, 2022Diabetes
T2D: Cardiovascular and safety outcomes associated first-line SGLT-2i vs. metforminJune 22, 2022Diabetes
